Literature DB >> 22244697

The role of non-covalent interactions in anticancer drug loading and kinetic stability of polymeric micelles.

Chuan Yang1, Amalina B Ebrahim Attia, Jeremy P K Tan, Xiyu Ke, Shujun Gao, James L Hedrick, Yi-Yan Yang.   

Abstract

A new series of acid- and urea-functionalized polycarbonate block copolymers were synthesized via organocatalytic living ring-opening polymerization using methoxy poly(ethylene glycol) (PEG) as a macroinitiator to form micelles as drug delivery carriers. The micelles were characterized for critical micelle concentration, particle size and size distribution, kinetic stability and loading capacity for a model anticancer drug, doxorubicin (DOX) having an amine group. The acid/urea groups were placed in block forms (i.e. acid as the middle block or the end block) or randomly distributed in the polycarbonate block to investigate molecular structure effect. The micelles formed from the polymers in both random and block forms provided high drug loading capacity due to strong ionic interaction between the acid in the polymer and the amine in DOX. However, the polymers with acid and urea groups placed in the block forms formed micelles with wider size distribution (two size populations), and their DOX-loaded micelles were less stable. The number of acid/urea groups in the random form was further varied from 5 to 8, 13 and 19 to study its effects on self-assembly behaviors and DOX loading. An increased number of acid/urea groups yielded DOX-loaded micelles with smaller size and enhanced kinetic stability because of improved inter-molecular polycarbonate-polycarbonate (urea-urea and urea-acid) hydrogen-bonding and polycarbonate-DOX (acid-amine) ionic interactions. However, when the number of acid/urea groups was 13 or higher, micelles aggregated in a serum-containing medium, and freeze-dried DOX-loaded micelles were unable to re-disperse in an aqueous solution. Among all the polymers synthesized in this study, 1b with 8 acid/urea groups in the random form had the optimum properties. In vitro release studies showed that DOX release from 1b micelles was sustained over 7 h without significant initial burst release. MTT assays demonstrated that the polymer was not toxic towards HepG2 and HEK293 cells. Importantly, DOX-loaded micelles were potent against HepG2 cells with IC(50) of 0.26 mg/L, comparable to that of free DOX (IC(50): 0.20 mg/L). In addition, DOX-loaded 1b micelles yielded lower DOX content in the heart tissue of the tested mice as compared to free DOX formulation after i.v. injection. These findings signify that 1b micelles may be a promising carrier for delivery of anticancer drugs that contain amine groups.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22244697     DOI: 10.1016/j.biomaterials.2011.11.035

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  18 in total

Review 1.  Polymeric micelles and cancer therapy: an ingenious multimodal tumor-targeted drug delivery system.

Authors:  Sharath Kumar Hari; Ankita Gauba; Neeraj Shrivastava; Ravi Mani Tripathi; Sudhir Kumar Jain; Akhilesh Kumar Pandey
Journal:  Drug Deliv Transl Res       Date:  2022-06-21       Impact factor: 4.617

2.  Therapeutic silencing of mTOR by systemically administered siRNA-loaded neutral liposomal nanoparticles inhibits DMBA-induced mammary carcinogenesis.

Authors:  Roja Sahu; Shakti Prasad Pattanayak; Shivesh Jha
Journal:  Br J Cancer       Date:  2022-10-19       Impact factor: 9.075

3.  Renaissance of Aliphatic Polycarbonates: New Techniques and Biomedical Applications.

Authors:  Jianwen Xu; Ellva Feng; Jie Song
Journal:  J Appl Polym Sci       Date:  2014-03-05       Impact factor: 3.125

Review 4.  Nanoparticle characterization: state of the art, challenges, and emerging technologies.

Authors:  Eun Jung Cho; Hillary Holback; Karen C Liu; Sara A Abouelmagd; Joonyoung Park; Yoon Yeo
Journal:  Mol Pharm       Date:  2013-03-21       Impact factor: 4.939

5.  Fmoc-conjugated PEG-vitamin E2 micelles for tumor-targeted delivery of paclitaxel: enhanced drug-carrier interaction and loading capacity.

Authors:  Yifei Zhang; Yixian Huang; Wenchen Zhao; Jianqin Lu; Peng Zhang; Xiaolan Zhang; Jiang Li; Xiang Gao; Raman Venkataramanan; Song Li
Journal:  AAPS J       Date:  2014-09-06       Impact factor: 4.009

6.  Strategies to improve micelle stability for drug delivery.

Authors:  Yang Lu; Ershuai Zhang; Jianhai Yang; Zhiqiang Cao
Journal:  Nano Res       Date:  2018-08-01       Impact factor: 8.897

Review 7.  Polymeric micelles: nanocarriers for cancer-targeted drug delivery.

Authors:  Yifei Zhang; Yixian Huang; Song Li
Journal:  AAPS PharmSciTech       Date:  2014-04-04       Impact factor: 3.246

8.  Vitamin E succinate-conjugated F68 micelles for mitoxantrone delivery in enhancing anticancer activity.

Authors:  Yuling Liu; Yingqi Xu; Minghui Wu; Lijiao Fan; Chengwei He; Jian-Bo Wan; Peng Li; Meiwan Chen; Hui Li
Journal:  Int J Nanomedicine       Date:  2016-07-12

9.  β-Cyclodextrin-Based Inclusion Complexation Bridged Biodegradable Self-Assembly Macromolecular Micelle for the Delivery of Paclitaxel.

Authors:  Yanzuo Chen; Yukun Huang; Dongdong Qin; Wenchao Liu; Chao Song; Kaiyan Lou; Wei Wang; Feng Gao
Journal:  PLoS One       Date:  2016-03-10       Impact factor: 3.240

10.  Cellular uptake and antitumor activity of DOX-hyd-PEG-FA nanoparticles.

Authors:  Wei-liang Ye; Jiang-bo Du; Bang-le Zhang; Ren Na; Yan-feng Song; Qi-bing Mei; Ming-gao Zhao; Si-yuan Zhou
Journal:  PLoS One       Date:  2014-05-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.